Medifast (MED)
NYSE Market Open
Medifast, Inc. is a health and wellness company best known for OPTAVIA, its coach-supported weight management and lifestyle platform. The company’s approach combines structured nutrition, community-based support, personal coaching, and habit formation to help customers pursue weight loss and long-term behavior change. Rather than operating solely as a diet product company, Medifast positions OPTAVIA as a broader lifestyle system built around daily routines, accountability, and education.
The company offers meal replacements and other nutrition products designed to simplify calorie and portion management, while independent coaches provide guidance and encouragement throughout the customer journey. This coaching model is central to Medifast’s business, as it supports customer acquisition, engagement, and retention through personal relationships and peer communities. The company’s messaging emphasizes sustainable lifestyle transformation and making healthier habits part of everyday life.
Medifast operates in a competitive weight management market that includes commercial diet programs, consumer packaged nutrition products, fitness and wellness platforms, medical weight-loss providers, and prescription obesity treatments. The rapid growth of GLP-1 medications has reshaped the industry, and Medifast has worked to incorporate access to these therapies where clinically appropriate while continuing to offer nutrition and behavior-change support.
For investors, MED is tied to trends in obesity care, consumer wellness spending, direct selling and coaching models, and demand for structured weight-loss solutions. Its performance depends on customer acquisition, coach productivity, product appeal, brand trust, regulatory compliance, and the company’s ability to adapt as medical and lifestyle approaches to weight management increasingly overlap.
Last updated
- Market Cap
- 137.43M
- P/E
- —
- P/FCF
- —
- P/S
- 0.4
- Enterprise Value
- 65.9M
- Sector
- —
- Industry
- —
- Address
- 1501 S. CLINTON STREET, BALTIMORE, MD, 21224
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation
Peer-Reviewed Research Is Redefining Weight Loss Program Standards
Weight Management Market Outlook to 2030: 7.6% CAGR as Digital Adoption Rises and Preventive Health Focus Strengthens, Says Mordor Intelligence
Plant-based Beverage Market is Estimated to Reach $56.73 Billion with a 11.9% CAGR By 2034 | Fact.MR Reports
Post Holdings (POST) Q3 Earnings Surpass Estimates
Medifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y
Wall Street Breakfast: The Week Ahead
Medifast's (MED) Transformation on Track Amid Macro Headwinds
MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
Innovations Aid Medifast (MED), Lower Customer Attraction Ails
Medifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/Y
Medifast (MED) Q4 Earnings and Revenues Surpass Estimates
Medifast (MED) Q4 Earnings Coming Up: What Should You Know?
Mondelez (MDLZ) Q4 Earnings and Revenues Top Estimates
Medifast's (MED) Holistic Health Solution, Innovation Bode Well
Medifast (MED) Collaborates With LifeMD, Discontinues Dividend
Dow Jones closes at record high as Federal Reserve signals interest-rate pivot
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 137.43M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 65.9M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.7
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.4
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -40.93
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.19
- EPS
- -1.8
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0.06%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 36.97
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- -1.47M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -10.13%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -7.94%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 4.8
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 4.3
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.7
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 197.85K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 12.36
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 76.04M | 75.1M | 89.41M | 105.56M | 115.73M |
| Gross profit | 51.76M | 52.14M | 62.16M | 76.64M | 84.25M |
| Operating income | -3.3M | -7.8M | -4.08M | -1.07M | -1.26M |
| EBITDA | 188K | -4.34M | -1.02M | 3.56M | 2.02M |
| Net income | -2.12M | -18.12M | -2.26M | 2.48M | -772K |
| Basic EPS | -0.19 | -1.65 | -0.21 | 0.23 | -0.07 |
| Diluted EPS | -0.19 | -1.65 | -0.21 | 0.22 | -0.07 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 252.05M | 247.97M | 268.21M | 269.33M | 280.01M |
| Total liabilities | 54.37M | 49.05M | 53.5M | 53.33M | 69.05M |
| Total equity | 197.68M | 198.92M | 214.71M | 216.01M | 210.96M |
| Cash & equivalents | 71.53M | 89.3M | 99.53M | 101.69M | 91.72M |
| Current assets | 202.63M | 201.68M | 207.84M | 206.44M | 213.52M |
| Current liabilities | 42.18M | 42.96M | 46.71M | 46.18M | 60.6M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 260K | -5.28M | 12.11M | -3.38M | 3.41M |
| Investing cash flow | -17.13M | -4.95M | -14.28M | 13.36M | -2.05M |
| Financing cash flow | -901K | 1K | 0 | -2K | -563K |
| Change in cash | -17.77M | -10.22M | -2.17M | 9.98M | 789K |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — MEDIFAST INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 3 — MEDIFAST INC | View Filing | |
| edgar index | 3 — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| form 3 | Form 3 — Kiai Parsa | View Filing | |
| edgar index | 8-K — MEDIFAST INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Xian Ming | View Filing | |
| form 4 | Form 4 — Geary Elizabeth A. | View Filing | |
| form 4 | Form 4 — SCHLACKMAN SCOTT | View Filing | |
| form 4 | Form 4 — Thomas Andrea B | View Filing | |
| form 4 | Form 4 — Kiai Parsa | View Filing | |
| form 4 | Form 4 — Kiai Parsa | View Filing | |
| form 4 | Form 4 — Rose Jeffrey Matthew | View Filing | |
| form 4 | Form 4 — Rose Jeffrey Matthew | View Filing | |
| edgar index | SCHEDULE 13G — MEDIFAST INC | View Filing | |
| edgar index | SCHEDULE 13G/A — MEDIFAST INC | View Filing | |
| edgar index | SCHEDULE 13G/A — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| form 4 | Form 4 — SCHLACKMAN SCOTT | View Filing | |
| form 4 | Form 4 — SCHLACKMAN SCOTT | View Filing | |
| edgar index | 8-K — MEDIFAST INC | View Filing | |
| edgar index | 10-Q — MEDIFAST INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — MEDIFAST INC | View Filing | |
| edgar index | DEFA14A — MEDIFAST INC | View Filing | |
| edgar index | ARS — MEDIFAST INC | View Filing | |
| edgar index | SCHEDULE 13G/A — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| edgar index | 4 — MEDIFAST INC | View Filing | |
| edgar index | 3 — MEDIFAST INC | View Filing | |
| form 3 | Form 3 — Johnson Nicholas Mark | View Filing | |
| form 3 | Form 3 — Johnson Nicholas Mark | View Filing | |
| form 3 | Form 3 — Johnson Nicholas Mark | View Filing | |
| form 3 | Form 3 — Johnson Nicholas Mark | View Filing | |
| form 3 | Form 3 — Johnson Nicholas Mark | View Filing | |
| form 4 | Form 4 — Chard Daniel R | View Filing | |
| form 4 | Form 4 — Chard Daniel R | View Filing | |
| form 4 | Form 4 — Chard Daniel R | View Filing | |
| form 4 | Form 4 — Maloney James P. | View Filing | |
| form 4 | Form 4 — Maloney James P. | View Filing | |
| form 4 | Form 4 — Maloney James P. | View Filing | |
| form 4 | Form 4 — MacKenzie Jonathan Barrett | View Filing | |
| form 4 | Form 4 — MacKenzie Jonathan Barrett | View Filing | |
| edgar index | SCHEDULE 13D — MEDIFAST INC | View Filing | |
| edgar index | 8-K — MEDIFAST INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Chard Daniel R | View Filing | |
| form 4 | Form 4 — Chard Daniel R | View Filing | |
| form 4 | Form 4 — Maloney James P. | View Filing | |
| form 4 | Form 4 — MacKenzie Jonathan Barrett | View Filing | |
| form 4 | Form 4 — Chard Daniel R | View Filing | |
| form 4 | Form 4 — Chard Daniel R | View Filing | |
| form 4 | Form 4 — Maloney James P. | View Filing | |
| form 4 | Form 4 — MacKenzie Jonathan Barrett | View Filing | |
| edgar index | 8-K — MEDIFAST INC | View Filing | |
| edgar index | 10-K — MEDIFAST INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13G/A — MEDIFAST INC | View Filing | |
| edgar index | SCHEDULE 13G/A — MEDIFAST INC | View Filing | |
| edgar index | 8-K — MEDIFAST INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — MEDIFAST INC | View Filing | |
| edgar index | SCHEDULE 13G/A — MEDIFAST INC | View Filing | |
| edgar index | 8-K — MEDIFAST INC | View Filing |